- Home
- ELWT vs NRXS Comparison
ELWT vs NRXS Comparison
Compare ELWT & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELWT | NRXS |
|---|---|---|
| Founded | 2002 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.6M | 46.3M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | ELWT | NRXS |
|---|---|---|
| Price | $7.05 | $6.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $8.00 |
| AVG Volume (30 Days) | 57.7K | ★ 104.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.89 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,685,925.00 |
| Revenue This Year | $167.76 | $31.05 |
| Revenue Next Year | $22.42 | $146.31 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.18 |
| 52 Week Low | $4.11 | $1.33 |
| 52 Week High | $8.25 | $6.34 |
Technical Indicators
Market Signals| Indicator | ELWT | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 64.68 | 63.91 |
| Support Level | $4.26 | $2.28 |
| Resistance Level | $8.15 | $6.20 |
| Average True Range (ATR) | 0.74 | 0.50 |
| MACD | 0.10 | 0.08 |
| Stochastic Oscillator | 70.78 | 78.65 |
Price Performance
Historical ComparisonAbout ELWT Elauwit Connection Inc.
Elauwit Connection Inc is a customer-centric service provider of broadband Internet networks for the multifamily and student housing property sectors across the United States. The company generates revenue from the following sources: network design and installation and internet network services. It provides service offering wholesale to REITs, property ownership groups, and property management companies, engaged in its target real estate sectors.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).